Read on PBS NewsFDA Approves First New OTC Sunscreen Ingredient in 25 Years: What You Need to Know About Bemotrizinol
In a landmark move for sun protection, the FDA has approved bemotrizinol (BEMT) as the first new active ingredient for over-the-counter sunscreens in over 25 years. This advanced ingredient, widely used in Europe and Asia since the 1990s, offers superior broad-spectrum protection against both UVA and UVB rays with minimal skin absorption. Dermatologists hail it as a significant upgrade, providing a more cosmetically elegant, less irritating alternative to traditional mineral sunscreens. The approval, effective August 9, 2026, follows years of advocacy by the American Academy of Dermatology and addresses growing consumer concerns about sunscreen safety. This article explores why the approval took so long, how BEMT works, its benefits for sensitive skin, and what consumers can expect in the coming months.
For the first time in more than 25 years, the U.S. Food and Drug Administration (FDA) has approved a new active ingredient for over-the-counter sunscreens. This long-awaited decision clears the way for manufacturers to begin using bemotrizinol, also known as BEMT, an ingredient that has been a staple in sun protection products across Europe and Asia since the 1990s. The approval, effective August 9, 2026, marks a significant milestone in the ongoing effort to improve sun protection options for American consumers.
Dermatologist Dr. Rachel Nazarian recently discussed the implications of this approval with Amna Nawaz on the PBS NewsHour. According to Dr. Nazarian, BEMT is a unique ingredient that excels at blocking both UVA and UVB rays, offering broad-spectrum protection without the common drawbacks of mineral sunscreens. "Typically, we had mineral sunscreens that were always giving that white cast on the skin, but they did a fantastic job of blocking broad spectrum ultraviolet light. BEMT can do that, but it goes on much nicer and has negligible absorption into the system, meaning it's even safer," she explained.
Why Did the Approval Take So Long?
The lengthy approval process has been a source of frustration for dermatologists and consumers alike. While BEMT has been used safely and effectively internationally for decades, the FDA's regulatory requirements for new sunscreen ingredients are particularly rigorous. Dr. Nazarian noted that some of the required testing and legislation were "a little bit tedious" and that the U.S. system did not fully leverage the safety data already available from international use. The American Academy of Dermatology actively pushed for legislative changes to expedite the approval of globally recognized, safe ingredients, aiming to prevent such delays in the future.
Benefits of Bemotrizinol for Consumers
For consumers, the approval of BEMT represents a significant upgrade in sunscreen technology. Dr. Nazarian describes it as an "absolute upgrade" over many existing options. Many patients have historically traveled to Europe or Asia to purchase sunscreens with superior cosmetic elegance and protection. BEMT-based sunscreens are expected to feel great on the skin, be less irritating, and still provide exceptional protection against sun damage and skin cancers. Because BEMT is a large, bulky molecule that is minimally absorbed into the bloodstream, it addresses growing consumer concerns about the systemic absorption of sunscreen chemicals. This makes it an excellent choice for individuals with sensitive skin or those worried about potential toxicity.
Addressing Consumer Safety Concerns
The FDA's approval comes at a time when a growing number of Americans express skepticism about sunscreen safety. A consumer analysis by CivicScience found that the percentage of Americans who believe sunscreen is toxic grew from 17 percent in 2021 to 24 percent in 2025. Dr. Nazarian acknowledges these concerns but emphasizes that the new ingredient is a step forward. "If you can have something like bemotrizinol, which is a really large bulky molecule, not absorbed, then certainly people should feel a little bit safer about that. What we're really looking for is something that doesn't enter the bloodstream, and bemotrizinol has proven itself very, very safe."
When Will BEMT Sunscreens Be Available?
Manufacturers can begin incorporating bemotrizinol as an active ingredient starting August 9, 2026. Initially, one company will have exclusivity for approximately 18 months, meaning products will be available from a single brand. However, many internationally recognized U.S. brands already use BEMT in their products sold abroad, so the transition to the domestic market should be swift. After the exclusivity period ends, Dr. Nazarian expects BEMT sunscreens to become widely available at local drugstores, offering consumers more options.
Broader Sun Protection Advice
While the new ingredient is a welcome development, Dr. Nazarian reminds the public that sunscreen is just one part of a comprehensive sun protection strategy. Skin cancer, particularly basal cell and squamous cell carcinomas, is one of the most preventable cancers in the United States. Alongside sunscreen, individuals should use sun-protective clothing like hats and rash guards and avoid peak sun hours when UV radiation is strongest. Having five or more sunburns doubles the risk of melanoma, and about 90 percent of non-melanoma skin cancers are linked to UV overexposure.
The approval of bemotrizinol is a positive step toward safer, more effective sun protection in the United States, offering consumers a powerful new tool to protect their skin health.
